IL6 and rheumatoid arthritis: In relation to the aim of the combination products to reduce excessive immune response, both indomethacin and naproxen have shown to reduce interleukin (IL)-6 in the plasma and synovial fluids of rheumatoid arthritis patients [36], and in another study indomethacin reduced inflammation in Alzheimer patients [37].